YANG MICHAEL J. — SEC Form 4 filings
SEC reporting owner CIK 1702283. 12 Form 4 filings on record with FilingPulse; latest filed 2026-07-06.
Transaction summary — filings shown
Covers all 12 filings on record, filed 2024-01-17 to 2026-07-06. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing — 2,000 shares, $25,800 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 19.
- Largest priced transaction: purchase of 2,000 shares @ $12.90 ($25,800) in Pacira BioSciences, Inc., filed 2024-08-14.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Pacira BioSciences, Inc. (PCRX) | Director | 4 | 1 leg · 2,000 sh · $25,800 | — | 6 |
| IONIS PHARMACEUTICALS INC (IONS) | Director | 8 | — | — | 13 |
Form 4 filings — YANG MICHAEL J.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-06 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Grant/award (A): 5,369 (derivative) @ $0 · Grant/award (A): 2,301 (derivative) @ $0 | EDGAR |
| 2026-06-12 | 4 | Pacira BioSciences, Inc. (PCRX) | Grant/award (A): 6,405 @ $0 · Grant/award (A): 10,891 (derivative) @ $0 | EDGAR |
| 2026-01-20 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Option exercise (M): 1,930 @ $0 · Option exercise (M): 1,930 (derivative) @ $0 | EDGAR |
| 2025-07-17 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Option exercise (M): 4,079 @ $0 · Option exercise (M): 4,079 (derivative) @ $0 | EDGAR |
| 2025-07-02 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Grant/award (A): 11,518 (derivative) @ $0 · Grant/award (A): 5,220 (derivative) @ $0 | EDGAR |
| 2025-06-13 | 4 | Pacira BioSciences, Inc. (PCRX) | Grant/award (A): 6,163 @ $0 · Grant/award (A): 11,279 (derivative) @ $0 | EDGAR |
| 2025-01-17 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Option exercise (M): 1,931 @ $0 · Option exercise (M): 1,931 (derivative) @ $0 | EDGAR |
| 2024-08-14 | 4 | Pacira BioSciences, Inc. (PCRX) | Purchase (P): 2,000 @ $12.90 | EDGAR |
| 2024-07-03 | 4/A | IONIS PHARMACEUTICALS INC (IONS) | Grant/award (A): 4,079 (derivative) @ $0 | EDGAR |
| 2024-07-03 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Grant/award (A): 10,111 (derivative) @ $0 | EDGAR |
| 2024-06-13 | 4 | Pacira BioSciences, Inc. (PCRX) | Grant/award (A): 5,230 @ $0 · Grant/award (A): 12,179 (derivative) @ $0 | EDGAR |
| 2024-01-17 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Grant/award (A): 5,791 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1702283 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →